Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions.
Explore this paper's citation graph
Summary
The potential for estrogen replacement therapy to reduce angiographic measures of restenosis in postmenopausal women after coronary intervention is demonstrated, particularly in those undergoing atherectomy.
- Type
- article
- Published
- 1996-11-01
- Cited by
- 90
- References
- 38
- Access
- Open access
- OpenAlex
- https://openalex.org/W1986197226
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:5225812
Keywords
Medicine, Restenosis, Estrogen, Cardiology, Angioplasty
References
- 17-β estradiol inhibits neointima formation after coronary angioplasty in swine
- Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.
- Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
- Estrogen modulates responses of atherosclerotic coronary arteries.
- Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women.
- Can restenosis after coronary angioplasty be predicted from clinical variables?
- Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.
- Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
- Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
- Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome.
- The emerging concept of vascular remodeling.
- Estradiol inhibition of arterial neointimal hyperplasia after balloon injury.
- Acute Vascular Effects of Estrogen in Postmenopausal Women
- Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries.
- 901–40 Gender-related Differences in Smooth Muscle Cell Proliferation in Response to Estradiol and Dihydrotestosterone
- Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.
- Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.
- Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy.
- Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.
- Restenosis after successful coronary angioplasty in patients with single-vessel disease.
Cited by
- Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial.
- Medical and surgical management of coronary artery disease in women.
- Women's angiographic vitamin and estrogen trial: design and methods.
- Coronary Heart Disease
- Molecular Cardiology in Clinical Practice
- The effect of 17beta-estradiol, and the phytoestrogens genistein and daidzein on neointima development in endothelium-denuded female rabbit aortae--an in vitro study.
- Reduction of post injury neointima formation due to 17β-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro
- Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
- Estrogen‐eluting, phosphorylcholine‐coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model
- The Heart and Estrogen/Progestin Replacement Study
- The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
- The Use of Hormone Replacement Therapy in Postmenopausal Women with Type 2 Diabetes
- Prevention and Treatment of Coronary Heart Disease: Who Benefits?
- The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
- Effect of gender on angioplasty outcome: are we closer to the answer?
- The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
- Cardiovascular effects of estrogen.
- Hormone Replacement Therapy for Prevention or Treatment of Atherosclerosis in Postmenopausal Women
- Estrogen replacement therapy after coronary angioplasty in women.
- Medical therapies for the prevention of restenosis after percutaneous coronary interventions.
Related papers
- Optimal use of directional coronary atherectomy is required to ensure long-term angiographic benefit: a study with matched procedural outcome after atherectomy and angioplasty.
- Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.
- Restenosis after directional coronary atherectomy and balloon angioplasty: comparative analysis based on matched lesions.
- Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty.
- Insufficient tissue ablation by rotational atherectomy leads to worse long‐term results in comparison with balloon angioplasty alone for the treatment of diffuse in‐stent restenosis: Insights from the intravascular ultrasound substudy of the ARTIST randomized multicenter trial
- Early Changes in Minimal Luminal Diameter After Balloon Angioplasty and Directional Coronary Atherectomy.
- Predictors of event-free survival after repeat intracoronary procedure for in-stent restenosis; study with angiographic and intravascular ultrasound imaging.